Amedeo's Top 20

Amedeo Smart

Independent Medical Education

13 May 2024

Multidisciplinary Journal Club

  1. Carlton JM, Cunnington AJ.
    Zombie malaria parasites.
    Science 2024;384:513-514.

  1. Kim J, Cho J, Lee MH, Yoon SE, et al.
    Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis.
    Blood 2024.

  2. Metaxa AM, Clarke M.
    Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
    BMJ 2024;385:e078084.

  3. Wiles MD, Iliff HA, Brooks K, Da Silva EJ, et al.
    Airway management in patients with suspected or confirmed cervical spine injury: Guidelines from the Difficult Airway Society (DAS), Association of Anaesthetists (AoA), British Society of Orthopaedic Anaesthetists (BSOA), Intens
    Anaesthesia 2024.

  4. Schini M, Vilaca T, Lui LY, Ewing SK, et al.
    Pre-treatment bone mineral density (BMD) and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project.
    J Bone Miner Res 2024.

  1. DiMauro KA, Swetlik C, Cohen JA.
    Management of multiple sclerosis in older adults: review of current evidence and future perspectives.
    J Neurol 2024.

  2. Baum ML, Widge AS, Carpenter LL, McDonald WM, et al.
    Pharmacogenomic Clinical Support Tools for the Treatment of Depression.
    Am J Psychiatry 2024.

  3. Pasternak B, Wintzell V, Hviid A, Eliasson B, et al.
    Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    BMJ 2024;385:e078225.

  4. Cohen F, Brooks CV, Sun D, Buse DC, et al.
    Prevalence and burden of migraine in the United States: A systematic review.
    Headache 2024.

  5. Anderson CC, Iser CR, Hirte IL, Boddu S, et al.
    Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders-A retrospective tolerability and safety study.
    Headache 2024.

  1. Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, et al.
    EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
    Eur Urol 2024.

  2. Simon GE, Rossom RC, Iturralde E, Ahmedani BK, et al.
    Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine.
    J Clin Psychiatry 2024;85.

  3. Preziosa P, Rocca MA, Filippi M.
    Radiologically isolated syndromes: to treat or not to treat?
    J Neurol 2024;271:2370-2378.

  4. D'Aquino S, Kumar A, Riordan B, Callinan S, et al.
    Long-term effects of alcohol consumption on anxiety in adults: A systematic review.
    Addict Behav 2024;155:108047.

  5. Sass L, Feyaerts J.
    Schizophrenia, the very idea: On self-disorder, hyperreflexivity, and the diagnostic concept.
    Schizophr Res 2024.

  1. Fazio SA, Cortes-Puch I, Stocking JC, Doroy AL, et al.
    Early Mobility Index and Patient Outcomes: A Retrospective Study in Multiple Intensive Care Units.
    Am J Crit Care 2024;33:171-179.

  2. Bologna E, Licari LC, Franco A, Ditonno F, et al.
    Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis from a National Database.
    Urology 2024.

  3. Hartanto A, Wong J, Lua VYQ, Tng GYQ, et al.
    A Daily Diary Investigation of the Fear of Missing Out and Diminishing Daily Emotional Well-Being: The Moderating Role of Cognitive Reappraisal.
    Psychol Rep 2024;127:1117-1155.


    4. more..

    Privacy Policy